Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


26.08.2019

3 Acta Ophthalmol
3 Ann Intern Med
1 Atherosclerosis
1 BMC Ophthalmol
2 BMJ
1 Circulation
2 Clin Chem
5 Diabet Med
7 Diabetes
14 Diabetes Care
2 Diabetes Educ
1 Diabetes Obes Metab
1 Diabetologia
1 Eur J Endocrinol
1 Invest Ophthalmol Vis Sci
1 J Am Coll Cardiol
1 J Biol Chem
1 J Clin Invest
3 J Diabetes Complications
3 JAMA
1 Kidney Int
5 Lancet
5 Lancet Diabetes Endocrinol
1 Med J Aust
6 Pediatr Diabetes
6 PLoS One
1 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Ophthalmol

  1. LI T, Jia Y, Wang S, Xu Y, et al
    Change in peripapillary and macular choroidal thickness change in children with type 1 diabetes mellitus without visual impairment or diabetic retinopathy.
    Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14225.
    PubMed     Text format     Abstract available

  2. SHEN Y, Cao H, Chen F, Suo Y, et al
    A cross-sectional study of vitreous and serum high mobility group box-1 levels in proliferative diabetic retinopathy.
    Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14228.
    PubMed     Text format     Abstract available

  3. ZUR D, Iglicki M, Sala-Puigdollers A, Chhablani J, et al
    Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.
    Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14230.
    PubMed     Text format     Abstract available


    Ann Intern Med

  4. LIPSCOMBE LL
    In uncontrolled type 2 diabetes, adjunctive semaglutide reduced HbA1c and body weight vs sitagliptin.
    Ann Intern Med. 2019;171:JC16.
    PubMed     Text format    

  5. GOEL A
    In type 2 diabetes, a primary care-led weight management program increased weight loss and diabetes remission at 2 years.
    Ann Intern Med. 2019;171:JC17.
    PubMed     Text format    

  6. PATEL T
    Canagliflozin reduced kidney failure and CV events at 2.6 years in type 2 diabetes with chronic kidney disease.
    Ann Intern Med. 2019;171:JC15.
    PubMed     Text format    


    Atherosclerosis

  7. MORELLI MB, Wang X, Santulli G
    Functional role of gut microbiota and PCSK9 in the pathogenesis of diabetes mellitus and cardiovascular disease.
    Atherosclerosis. 2019 Jul 30. pii: S0021-9150(19)31425.
    PubMed     Text format    


    BMC Ophthalmol

  8. WANG H, Tao Y
    Choroidal structural changes correlate with severity of diabetic retinopathy in diabetes mellitus.
    BMC Ophthalmol. 2019;19:186.
    PubMed     Text format     Abstract available


    BMJ

  9. MAHASE E
    Progress in diabetes care has not improved outcomes in US, study finds.
    BMJ. 2019;366:l5166.
    PubMed     Text format    

  10. BROWN TJ, Brainard J, Song F, Wang X, et al
    Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials.
    BMJ. 2019;366:l4697.
    PubMed     Text format     Abstract available


    Circulation

  11. VERMA S, Mazer CD, Yan AT, Mason T, et al
    Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial.
    Circulation. 2019 Aug 22. doi: 10.1161/CIRCULATIONAHA.119.042375.
    PubMed     Text format     Abstract available


    Clin Chem

  12. PRICKETT TCR, Lunt H, Warwick J, Heenan HF, et al
    Urinary Amino-Terminal Pro-C-Type Natriuretic Peptide: A Novel Marker of Chronic Kidney Disease in Diabetes.
    Clin Chem. 2019 Aug 20. pii: clinchem.2019.306910.
    PubMed     Text format     Abstract available

  13. MONTEIRO MB, Santos-Bezerra DP, Pelaes TS, Vaidya VS, et al
    MicroRNAs 1915-3p, 2861, and 4532 Are Associated with Long-Term Renal Function Decline in Type 1 Diabetes.
    Clin Chem. 2019 Aug 19. pii: clinchem.2019.307686.
    PubMed     Text format    


    Diabet Med

  14. WISTING L, Snoek F
    Terminology matters: 'diabulimia' is insufficient to describe eating disorders in individuals with Type 1 diabetes.
    Diabet Med. 2019 Aug 16. doi: 10.1111/dme.14108.
    PubMed     Text format    

  15. BACHMANN MO, Lewis G, John WG, Turner J, et al
    Determinants of diagnostic discordance for non-diabetic hyperglycaemia and Type 2 diabetes using paired glycated haemoglobin measurements in a large English primary care population: cross-sectional study.
    Diabet Med. 2019 Aug 17. doi: 10.1111/dme.14111.
    PubMed     Text format     Abstract available

  16. LAKE A, Arthur A, Byrne C, Davenport K, et al
    The effect of hypoglycaemia during hospital admission on health-related outcomes for people with diabetes: a systematic review and meta-analysis.
    Diabet Med. 2019 Aug 23. doi: 10.1111/dme.14115.
    PubMed     Text format     Abstract available

  17. CARRILLO-LARCO RM, Aparcana-Granda DJ, Mejia JR, Barengo NC, et al
    Risk scores for Type 2 diabetes mellitus in Latin America: a systematic review of population-based studies.
    Diabet Med. 2019 Aug 23. doi: 10.1111/dme.14114.
    PubMed     Text format     Abstract available

  18. GARRETT CJ, Choudhary P, Amiel SA, Fonagy P, et al
    Recurrent diabetic diabetic ketoacidosis and a brief history of brittle diabetes research: contemporary and past evidence in diabetic diabetic ketoacidosis research including mortality, mental health and prevention.
    Diabet Med. 2019 Aug 16. doi: 10.1111/dme.14109.
    PubMed     Text format     Abstract available


    Diabetes


  19. In This Issue of Diabetes.
    Diabetes. 2019;68:1707-1708.
    PubMed     Text format    

  20. BERGMAN RN, Piccinini F, Kabir M, Kolka CM, et al
    Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes.
    Diabetes. 2019;68:1709-1716.
    PubMed     Text format     Abstract available

  21. KO KI, Syverson AL, Kralik RM, Choi J, et al
    Diabetes-Induced NF-kappaB Dysregulation in Skeletal Stem Cells Prevents Resolution of Inflammation.
    Diabetes. 2019 Aug 22. pii: db19-0496. doi: 10.2337/db19-0496.
    PubMed     Text format     Abstract available

  22. CHENG Y, Liu J, Luan Y, Liu Z, et al
    Sarm1 Gene Deficiency Attenuates Diabetic Peripheral Neuropathy in Mice.
    Diabetes. 2019 Aug 22. pii: db18-1233. doi: 10.2337/db18-1233.
    PubMed     Text format     Abstract available

  23. GAO S, Chen Y, Sang F, Yang Y, et al
    White Matter Microstructural Change Contributes to Worse Cognitive Function in Type 2 Diabetes Mellitus Patients.
    Diabetes. 2019 Aug 22. pii: db19-0233. doi: 10.2337/db19-0233.
    PubMed     Text format     Abstract available

  24. VUORI N, Sandholm N, Kumar A, Hietala K, et al
    CACNB2 is a Novel Susceptibility Gene for Diabetic Retinopathy in Type 1 Diabetes.
    Diabetes. 2019 Aug 22. pii: db19-0130. doi: 10.2337/db19-0130.
    PubMed     Text format     Abstract available

  25. TAN X, Hu L, Shu Z, Chen L, et al
    Role of CCR2 in the Development of Streptozotocin-treated Diabetic Cardiomyopathy.
    Diabetes. 2019 Aug 22. pii: db18-1231. doi: 10.2337/db18-1231.
    PubMed     Text format     Abstract available


    Diabetes Care

  26. PRATTE KA, Johnson A, Beals J, Bullock A, et al
    Erratum. Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention Program. Diabetes Care 2019;42:1209-1216.
    Diabetes Care. 2019 Aug 20. pii: dc19-er10. doi: 10.2337.
    PubMed     Text format    

  27. MOULTON CD, Pickup JC, Rokakis AS, Amiel SA, et al
    The Prospective Association Between Inflammation and Depressive Symptoms in Type 2 Diabetes Stratified by Sex.
    Diabetes Care. 2019 Aug 15. pii: dc19-0813. doi: 10.2337/dc19-0813.
    PubMed     Text format     Abstract available

  28. RUDLAND VL, Pinner J, Ross GP
    Congenital Anomalies in Offspring of Maternal Glucokinase-Maturity-Onset Diabetes of the Young: A Case Report.
    Diabetes Care. 2019 Aug 15. pii: dc19-0930. doi: 10.2337/dc19-0930.
    PubMed     Text format    

  29. DE VRIES TI, Dorresteijn JAN, van der Graaf Y, Visseren FLJ, et al
    Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial.
    Diabetes Care. 2019 Aug 15. pii: dc19-0776. doi: 10.2337/dc19-0776.
    PubMed     Text format     Abstract available

  30. CAVAGNUOLO L, Bozzetto L, Franco L, Costabile G, et al
    Pizza Leavening Technique Influences Postprandial Glucose Response: A Randomized Controlled Trial in Patients With Type 1 Diabetes.
    Diabetes Care. 2019 Aug 15. pii: dc19-0778. doi: 10.2337/dc19-0778.
    PubMed     Text format    

  31. CLIMIE RE, van Sloten TT, Perier MC, Tafflet M, et al
    Change in Cardiovascular Health and Incident Type 2 Diabetes and Impaired Fasting Glucose: The Whitehall II Study.
    Diabetes Care. 2019 Aug 15. pii: dc19-0379. doi: 10.2337/dc19-0379.
    PubMed     Text format     Abstract available

  32. VAN BAAR MJB, van Ruiten CC, Muskiet MHA, van Bloemendaal L, et al
    Erratum. SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management. Diabetes Care 2018;41:1543-1556.
    Diabetes Care. 2019 Aug 20. pii: dc19-er10a. doi: 10.2337.
    PubMed     Text format    

  33. LEE M, Sun J, Han M, Cho Y, et al
    Nationwide Trends in Pancreatitis and Pancreatic Cancer Risk Among Patients With Newly Diagnosed Type 2 Diabetes Receiving Dipeptidyl Peptidase-4 Inhibitors.
    Diabetes Care. 2019 Aug 20. pii: dc18-2195. doi: 10.2337/dc18-2195.
    PubMed     Text format     Abstract available


  34. In This Issue of Diabetes Care.
    Diabetes Care. 2019;42:1607-1608.
    PubMed     Text format    

  35. O'CONNELL JM, Manson SM
    Understanding the Economic Costs of Diabetes and Prediabetes and What We May Learn About Reducing the Health and Economic Burden of These Conditions.
    Diabetes Care. 2019;42:1609-1611.
    PubMed     Text format    

  36. WEBER MB, Narayan KMV
    Health Insurance for Diabetes Prevention Confers Health Benefits and Breaks Even on Cost Within 2 Years.
    Diabetes Care. 2019;42:1612-1614.
    PubMed     Text format    

  37. MILEI J, Azzato F, Rodriguez-Granillo GA
    Comment on Elliott et al. Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up. Diabetes Care 2019;42:1290-1296.
    Diabetes Care. 2019;42:e155.
    PubMed     Text format    

  38. ELLIOTT MD, Heitner JF, Kim H, Wu E, et al
    Response to Comment on Elliott et al. Prevalence and Prognosis of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes: A Two-Center Study With Up to 5 Years of Follow-up. Diabetes Care 2019;42:1290-1296.
    Diabetes Care. 2019;42:e156.
    PubMed     Text format    

  39. JEHL A, Cugnet-Anceau C, Vigouroux C, Legeay AL, et al
    Acquired Generalized Lipodystrophy: A New Cause of Anti-PD-1 Immune-Related Diabetes.
    Diabetes Care. 2019 Aug 21. pii: dc18-2535. doi: 10.2337/dc18-2535.
    PubMed     Text format     Abstract available


    Diabetes Educ

  40. STRODEL RJ, Chang CH, Khurana SG, Camp AW, et al
    Increased Awareness, Unchanged Behavior: Prediabetes Diagnosis in a Low-Income, Minority Population.
    Diabetes Educ. 2019;45:203-213.
    PubMed     Text format    

  41. MENDEZ-LUCK CA, Miranda J, Mangione CM, Yoon J, et al
    The Juntos Pilot Study: A Diabetes Management Intervention for Latino Caregiving Dyads.
    Diabetes Educ. 2019 Aug 21:145721719866619. doi: 10.1177/0145721719866619.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  42. WATADA H, Kaneko S, Komatsu M, Ross Agner B, et al
    Superior HbA1c control with the fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with </=50 units insulin degludec in Japanese subjects with type 2 diabetes in a phase 3, double-blind, randomised trial.
    Diabetes Obes Metab. 2019 Aug 18. doi: 10.1111/dom.13859.
    PubMed     Text format     Abstract available


    Diabetologia

  43. BIESSELS GJ, Whitmer RA
    Cognitive dysfunction in diabetes: how to implement emerging guidelines.
    Diabetologia. 2019 Aug 16. pii: 10.1007/s00125-019-04977.
    PubMed     Text format     Abstract available


    Eur J Endocrinol

  44. WIUM-ANDERSEN IK, Osler M, Jorgensen MB, Rungby J, et al
    Antidiabetic medication and risk of dementia in patients with type 2 diabetes. A nested case-control study.
    Eur J Endocrinol. 2019 Aug 1. pii: EJE-19-0259.R1. doi: 10.1530/EJE-19-0259.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  45. TSAI MJ, Cheng CK, Wang YC
    Association of Body Fluid Expansion With Optical Coherence Tomography Measurements in Diabetic Retinopathy and Diabetic Macular Edema.
    Invest Ophthalmol Vis Sci. 2019;60:3606-3612.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  46. WANG A, Green JB, Halperin JL, Piccini JP Sr, et al
    Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2019;74:1107-1115.
    PubMed     Text format     Abstract available


    J Biol Chem

  47. NEUFER PD
    Cutting fuel offers new clues in diabetic mystery.
    J Biol Chem. 2019;294:12328-12329.
    PubMed     Text format     Abstract available


    J Clin Invest

  48. HUDISH LI, Reusch JE, Sussel L
    beta Cell dysfunction during progression of metabolic syndrome to type 2 diabetes.
    J Clin Invest. 2019 Aug 19. pii: 129188. doi: 10.1172/JCI129188.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  49. SHAO Y, Shao H, Sawhney MS, Shi L, et al
    Serum uric acid as a risk factor of all-cause mortality and cardiovascular events among type 2 diabetes population: Meta-analysis of correlational evidence.
    J Diabetes Complications. 2019 Jul 25:107409.
    PubMed     Text format     Abstract available

  50. GOYAL RK, Cristofaro V, Sullivan MP
    Rapid gastric emptying in diabetes mellitus: Pathophysiology and clinical importance.
    J Diabetes Complications. 2019 Aug 8:107414. doi: 10.1016/j.jdiacomp.2019.107414
    PubMed     Text format     Abstract available

  51. HUNT KJ, Jenkins AJ, Fu D, Stevens D, et al
    Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort.
    J Diabetes Complications. 2019 Jul 26:107410.
    PubMed     Text format     Abstract available


    JAMA

  52. RUBIN R
    Dr Schrier Goes to Congress as Second Woman Physician.
    JAMA. 2019;321:1443-1445.
    PubMed     Text format    

  53. FLORY J, Lipska K
    Metformin in 2019.
    JAMA. 2019;321:1926-1927.
    PubMed     Text format    

  54. ABBASI J
    Type 1 Diabetes Advances Could Pave Way for Prevention.
    JAMA. 2019 Aug 21. pii: 2748913. doi: 10.1001/jama.2019.10432.
    PubMed     Text format    


    Kidney Int

  55. BALMER LA, Whiting R, Rudnicka C, Gallo LA, et al
    Genetic characterization of early renal changes in a novel mouse model of diabetic kidney disease.
    Kidney Int. 2019 May 30. pii: S0085-2538(19)30510.
    PubMed     Text format     Abstract available


    Lancet

  56. HOORN EJ
    Testing the waters: a new test for hypotonic polyuria.
    Lancet. 2019;394:546-547.
    PubMed     Text format    

  57. BARNETT R
    Type 2 diabetes.
    Lancet. 2019;394:557.
    PubMed     Text format    

  58. ZELNIKER TA, Wiviott SD, Raz I, Sabatine MS, et al
    SGLT-2 inhibitors for people with type 2 diabetes - Authors' reply.
    Lancet. 2019;394:560-561.
    PubMed     Text format    

  59. STRANDBERG TE, Petrovic M, Benetos A
    SGLT-2 inhibitors for people with type 2 diabetes.
    Lancet. 2019;394:560.
    PubMed     Text format    

  60. MALAGA G, Ruiz EF
    SGLT-2 inhibitors for people with type 2 diabetes.
    Lancet. 2019;394:559-560.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  61. THE LANCET DIABETES ENDOCRINOL
    Type 1 diabetes technology: advances and challenges.
    Lancet Diabetes Endocrinol. 2019;7:657.
    PubMed     Text format    


  62. Correction to Lancet Diabetes Endocrinol 2019; 7: 665-67.
    Lancet Diabetes Endocrinol. 2019;7:e21.
    PubMed     Text format    

  63. KRISTENSEN SL, Rorth R, Jhund PS, Docherty KF, et al
    Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
    Lancet Diabetes Endocrinol. 2019 Aug 14. pii: S2213-8587(19)30249.
    PubMed     Text format     Abstract available

  64. DENNIS JM, Shields BM, Henley WE, Jones AG, et al
    Clusters provide a better holistic view of type 2 diabetes than simple clinical features - Authors' reply.
    Lancet Diabetes Endocrinol. 2019;7:669.
    PubMed     Text format    

  65. AHLQVIST E, Tuomi T, Groop L
    Clusters provide a better holistic view of type 2 diabetes than simple clinical features.
    Lancet Diabetes Endocrinol. 2019;7:668-669.
    PubMed     Text format    


    Med J Aust

  66. MCLACHLAN G, Keith C, Frauman A
    Diabetic ketoacidosis with sodium-glucose cotransporter type 2 inhibitors: a case series.
    Med J Aust. 2019 Aug 16. doi: 10.5694/mja2.50302.
    PubMed     Text format    


    Pediatr Diabetes

  67. GHANE N, Broadney MM, Davis EK, Trenschel RW, et al
    Estimating Plasma Glucose with the FreeStyle Libre Pro Continuous Glucose Monitor during Oral Glucose Tolerance Tests in Youth without Diabetes.
    Pediatr Diabetes. 2019 Aug 21. doi: 10.1111/pedi.12910.
    PubMed     Text format     Abstract available

  68. WIROMRAT P, Bjornstad P, Vinovskis C, Chung LT, et al
    Elevated Copeptin, Arterial Stiffness and Elevated Albumin Excretion in Adolescents with Type 1 Diabetes.
    Pediatr Diabetes. 2019 Aug 21. doi: 10.1111/pedi.12909.
    PubMed     Text format     Abstract available

  69. BACHA F, El Ghormli L, Arslanian S, Zeitler P, et al
    Predictors of response to insulin therapy in youth with poorly controlled type 2 diabetes in the TODAY trial.
    Pediatr Diabetes. 2019 Aug 16. doi: 10.1111/pedi.12906.
    PubMed     Text format     Abstract available

  70. HEGAB AM
    Prospective evaluation of insulin-to-carbohydrate ratio in children and adolescents with type 1 diabetes using multiple daily injection therapy.
    Pediatr Diabetes. 2019 Aug 21. doi: 10.1111/pedi.12911.
    PubMed     Text format     Abstract available

  71. NAGL K, Bollow E, Liptay S, Rosenbauer J, et al
    Lower HbA1c in patients with type 1 diabetes and celiac disease who reached celiac-specific antibody-negativity - a multicenter DPV analysis.
    Pediatr Diabetes. 2019 Aug 20. doi: 10.1111/pedi.12908.
    PubMed     Text format     Abstract available

  72. CLEMENTS MA, Schwandt A, Donaghue KC, Miller K, et al
    Five heterogeneous HbA1c trajectories from childhood to adulthood in youth with type 1 diabetes from three different continents - a group-based modeling approach.
    Pediatr Diabetes. 2019 Aug 16. doi: 10.1111/pedi.12907.
    PubMed     Text format     Abstract available


    PLoS One

  73. ZHANG Y, Huo W, Wen Y, Li H, et al
    Silencing Nogo-B receptor inhibits penile corpus cavernosum vascular smooth muscle cell apoptosis of rats with diabetic erectile dysfunction by down-regulating ICAM-1.
    PLoS One. 2019;14:e0220715.
    PubMed     Text format     Abstract available

  74. MKUU RS, Gilreath TD, Wekullo C, Reyes GA, et al
    Social determinants of hypertension and type-2 diabetes in Kenya: A latent class analysis of a nationally representative sample.
    PLoS One. 2019;14:e0221257.
    PubMed     Text format     Abstract available

  75. SOKOL JT, Schechet SA, Rosen DT, Ferenchak K, et al
    Outcomes of vitrectomy for diabetic tractional retinal detachment in Chicago's county health system.
    PLoS One. 2019;14:e0220726.
    PubMed     Text format     Abstract available

  76. LI YC
    Continuity of care for newly diagnosed diabetic patients: A population-based study.
    PLoS One. 2019;14:e0221327.
    PubMed     Text format     Abstract available

  77. ABDULMALEK SA, Balbaa M
    Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers.
    PLoS One. 2019;14:e0220779.
    PubMed     Text format     Abstract available

  78. ANG WJ, Zunaina E, Norfadzillah AJ, Raja-Norliza RO, et al
    Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients.
    PLoS One. 2019;14:e0221481.
    PubMed     Text format     Abstract available


    Transplant Proc

  79. BERMAN A, Wszola M, Gorski L, Serwanska-Swietek M, et al
    Islet Autotransplantation in Diabetic Patients.
    Transplant Proc. 2019 Aug 19. pii: S0041-1345(19)30140.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: